Global Prostate Cancer Diagnostics and Therapy market was valued at 13160 million in 2024 and is projected to reach USD 17590 million by 2032, at a CAGR of 4.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Prostate Cancer Diagnostics and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Therapy.
This report contains market size and forecasts of Prostate Cancer Diagnostics and Therapy in global, including the following market information:
- Global Prostate Cancer Diagnostics and Therapy market revenue, 2020-2025, 2026-2032, (D millions)
- Global top five Prostate Cancer Diagnostics and Therapy companies in 2024 (%)
Total Market by Segment:
Global Prostate Cancer Diagnostics and Therapy market, by Type, 2020-2025, 2026-2032 (D millions)
Global Prostate Cancer Diagnostics and Therapy market segment percentages, by Type, 2024 (%)
- Androgen Receptor-Directed Therapy
- Taxane-Based Chemotherapy
Global Prostate Cancer Diagnostics and Therapy market, by Application, 2020-2025, 2026-2032 (D millions)
Global Prostate Cancer Diagnostics and Therapy market segment percentages, by Application, 2024 (%)
Global Prostate Cancer Diagnostics and Therapy market, by region and country, 2020-2025, 2026-2032 (D millions)
Global Prostate Cancer Diagnostics and Therapy market segment percentages, by region and country, 2024 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Prostate Cancer Diagnostics and Therapy revenues in global market, 2020-2025 (estimated), (D millions)
- Key companies Prostate Cancer Diagnostics and Therapy revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Ipsen SA
- Pfizer Inc.
- Johnson & Johnson Services Inc.
- Bayer AG
- Abbvie Inc.
- Merck & Co. Inc.
- AstraZeneca PLC
- Thermo Fisher Scientific
- Dendreon Pharmaceuticals LLC
- F. Hoffmann-La Roche Ltd
- Hologic Inc.
- Astellas Pharma Inc.
- Koninklijke Philips NV
- Sanofi-Aventis
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Prostate Cancer Diagnostics and Therapy, market overview.
- Chapter 2: Global Prostate Cancer Diagnostics and Therapy market size in revenue.
- Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Prostate Cancer Diagnostics and Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Prostate Cancer Diagnostics and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Therapy Market Size: 2024 VS 2032
2.2 Global Prostate Cancer Diagnostics and Therapy Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Therapy Companies in Global Market, by Revenue in 2024
3.5 Global Companies Prostate Cancer Diagnostics and Therapy Product Type
3.6 Tier 1, Tier 2, and Tier 3 Prostate Cancer Diagnostics and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Market Size Markets, 2024 & 2032
4.1.2 Androgen Receptor-Directed Therapy
4.1.3 Taxane-Based Chemotherapy
4.2 Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
4.2.1 Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
5.2.1 Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Therapy Market Size, 2024 & 2032
6.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2020-2025
6.2.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2026-2032
6.2.3 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, 2020-2032
6.3.2 United States Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.3.3 Canada Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.3.4 Mexico Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, 2020-2032
6.4.2 Germany Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.3 France Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.4 U.K. Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.5 Italy Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.6 Russia Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.4.8 Benelux Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, 2020-2032
6.5.2 China Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.5.3 Japan Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.5.4 South Korea Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.5.6 India Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, 2020-2032
6.6.2 Brazil Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.6.3 Argentina Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, 2020-2032
6.7.2 Turkey Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.7.3 Israel Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
6.7.5 UAE Prostate Cancer Diagnostics and Therapy Market Size, 2020-2032
7 Companies Profiles
7.1 Ipsen SA
7.1.1 Ipsen SA Corporate Summary
7.1.2 Ipsen SA Business Overview
7.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.1.4 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.1.5 Ipsen SA Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.2.4 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Corporate Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.3.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.4.4 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Abbvie Inc.
7.5.1 Abbvie Inc. Corporate Summary
7.5.2 Abbvie Inc. Business Overview
7.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.5.4 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.5.5 Abbvie Inc. Key News & Latest Developments
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Corporate Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.6.4 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.6.5 Merck & Co. Inc. Key News & Latest Developments
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Corporate Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.7.4 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.7.5 AstraZeneca PLC Key News & Latest Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.8.4 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.8.5 Thermo Fisher Scientific Key News & Latest Developments
7.9 Dendreon Pharmaceuticals LLC
7.9.1 Dendreon Pharmaceuticals LLC Corporate Summary
7.9.2 Dendreon Pharmaceuticals LLC Business Overview
7.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.9.4 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.9.5 Dendreon Pharmaceuticals LLC Key News & Latest Developments
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.10.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.11 Hologic Inc.
7.11.1 Hologic Inc. Corporate Summary
7.11.2 Hologic Inc. Business Overview
7.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.11.4 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.11.5 Hologic Inc. Key News & Latest Developments
7.12 Astellas Pharma Inc.
7.12.1 Astellas Pharma Inc. Corporate Summary
7.12.2 Astellas Pharma Inc. Business Overview
7.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.12.4 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.12.5 Astellas Pharma Inc. Key News & Latest Developments
7.13 Koninklijke Philips NV
7.13.1 Koninklijke Philips NV Corporate Summary
7.13.2 Koninklijke Philips NV Business Overview
7.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.13.4 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.13.5 Koninklijke Philips NV Key News & Latest Developments
7.14 Sanofi-Aventis
7.14.1 Sanofi-Aventis Corporate Summary
7.14.2 Sanofi-Aventis Business Overview
7.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.14.4 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2020-2025)
7.14.5 Sanofi-Aventis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics and Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Therapy in Global Market
Table 5. Top Prostate Cancer Diagnostics and Therapy Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Prostate Cancer Diagnostics and Therapy Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Companies, 2020-2025
Table 8. Global Companies Prostate Cancer Diagnostics and Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2026-2032
Table 30. Ipsen SA Corporate Summary
Table 31. Ipsen SA Prostate Cancer Diagnostics and Therapy Product Offerings
Table 32. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 33. Ipsen SA Key News & Latest Developments
Table 34. Pfizer Inc. Corporate Summary
Table 35. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 36. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Johnson & Johnson Services Inc. Corporate Summary
Table 39. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 40. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 41. Johnson & Johnson Services Inc. Key News & Latest Developments
Table 42. Bayer AG Corporate Summary
Table 43. Bayer AG Prostate Cancer Diagnostics and Therapy Product Offerings
Table 44. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 45. Bayer AG Key News & Latest Developments
Table 46. Abbvie Inc. Corporate Summary
Table 47. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 48. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 49. Abbvie Inc. Key News & Latest Developments
Table 50. Merck & Co. Inc. Corporate Summary
Table 51. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 52. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 53. Merck & Co. Inc. Key News & Latest Developments
Table 54. AstraZeneca PLC Corporate Summary
Table 55. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 56. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 57. AstraZeneca PLC Key News & Latest Developments
Table 58. Thermo Fisher Scientific Corporate Summary
Table 59. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product Offerings
Table 60. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 61. Thermo Fisher Scientific Key News & Latest Developments
Table 62. Dendreon Pharmaceuticals LLC Corporate Summary
Table 63. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 64. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 65. Dendreon Pharmaceuticals LLC Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Ltd Corporate Summary
Table 67. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product Offerings
Table 68. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 69. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 70. Hologic Inc. Corporate Summary
Table 71. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 72. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 73. Hologic Inc. Key News & Latest Developments
Table 74. Astellas Pharma Inc. Corporate Summary
Table 75. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 76. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 77. Astellas Pharma Inc. Key News & Latest Developments
Table 78. Koninklijke Philips NV Corporate Summary
Table 79. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product Offerings
Table 80. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 81. Koninklijke Philips NV Key News & Latest Developments
Table 82. Sanofi-Aventis Corporate Summary
Table 83. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product Offerings
Table 84. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn) & (2020-2025)
Table 85. Sanofi-Aventis Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics and Therapy Product Picture
Figure 2. Prostate Cancer Diagnostics and Therapy Segment by Type in 2024
Figure 3. Prostate Cancer Diagnostics and Therapy Segment by Application in 2024
Figure 4. Global Prostate Cancer Diagnostics and Therapy Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Prostate Cancer Diagnostics and Therapy Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Prostate Cancer Diagnostics and Therapy Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2024
Figure 9. Segmentation by Type � Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 13. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 14. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 15. United States Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 19. Germany Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 20. France Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 27. China Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 31. India Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 33. Brazil Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2020-2032
Figure 36. Turkey Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2020-2032
Figure 40. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
